Pulmonology

2023 IASLC North America Conference on Lung Cancer Satellite Symposia

Burst CME™ - Part I – Overview of Pathophysiology, Diagnosis, and Management of HER3 Expressing Cancers

Burst CME™ - Part III – Advent of HER3 Targeted Approaches and Rationale in Breast Cancer Care

Burst CME™ - Part II – Advent of HER3 Targeted Approaches and Rationale in NSCLC Care

Show Me Your Care Plan™: Monitoring and Managing Patients With EGFR Exon20 Insertion+ NSCLC

Addressing Healthcare Inequities: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

Medical Crossfire®: Antibody-Drug Conjugates Coming to Your Oncology Practice Tomorrow

2nd Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™

Addressing Healthcare Inequities™: Tailoring Management Plans to Address Healthcare Disparities in Cystic Fibrosis

Community Practice Connections™: 17th Annual New York Lung Cancers Symposium

40th Annual CFS®: Innovative Cancer Therapy for Tomorrow®

Community Practice Connections™: 6th Annual Precision Medicine Through Plasma™ – Using Liquid Biopsies in Contemporary Oncology Care

Trekking Through the Latest Updates for ROS1-Targeted Therapies

Mapping Out the Role of Emerging Biomarkers and Testing in NSCLC

Navigating the Latest Data on NTRK-Targeted Therapies

21st Annual Winter Lung Cancer Conference®

Community Practice Connections™: Guidebook for Community Oncology NSCLC Treating Teams to Administer EGFR Exon 20-Targeted Regimens

1st Annual Hawaii Lung: A Multidisciplinary Case-Based Conference™

Advances In™ KRAS Inhibition: Modern Considerations In Targeting KRAS-Mutated Lung, Colorectal, And Pancreatic Cancers

How We Do It™: Integrating Gene Fusion Testing in Oncology Clinics for Patients with NSCLC

Community Practice Connections™: 20th Annual Winter Lung Conference

Medical Crossfire®: Key Strategies to Prioritize Testing and the Evolving Role of Genomic Alterations in Providing Precision NSCLC Care

Breaking Down Biomarkers in Non–Small Cell Lung Cancer: A Case-Based Discussion for the Oncology Nurse

The Top 10 Oncogenic Drivers in NSCLC for 2023: What You Need to Know on Tumor Testing, Targets, and Treatment Strategies to Move the Field Forward

Respiratory Syncytial Virus: Understanding the Infection Burden and Anticipating the Impact of Vaccines

Engaging the Multidisciplinary Care Team to Optimize Care of Patients With EGFR Mutation–Positive NSCLC: A Lung Cancer Tumor Board

Expanding the Armamentarium of Actionable Mutations in NSCLC: Uncovering the Potential of CEACAM5 as a Therapeutic Target

On-Demand Video Updates from the Annual Oncology Meeting

25th Annual International Lung Cancer Congress®

24th Annual International Lung Cancer Congress®